Livagen vs Pancragen
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Livagen
Khavinson liver bioregulator
Pancragen
Khavinson pancreatic bioregulator
About Livagen
Livagen is a Khavinson tetrapeptide bioregulator (Lys-Glu-Asp-Ala / KEDA) originally isolated from liver tissue extracts in Russian gerontology research. It has been studied in animal and cell-culture models for hepatocyte function, chromatin decondensation in lymphocytes, and liver-related ageing parameters, alongside other organ-targeted Khavinson peptides such as Pancragen and Cortagen. Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.
About Pancragen
Pancragen is a Khavinson short-peptide bioregulator (Lys-Glu-Asp-Trp / KEDW) originally isolated from pancreatic tissue extracts in Russian gerontology research. It has been studied in animal and cell-culture models for islet-cell function, glucose-handling parameters, and pancreatic tissue ageing, alongside other organ-targeted Khavinson tetrapeptides such as Livagen (liver) and Cortagen (cerebral cortex). Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.